Related Experiment Video

Updated: May 29, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

De-stiffening drug therapy and blood pressure control

Michel E Safar1

  • 1Paris-Descartes University, Faculty of Medicine, Hôtel-Dieu Hospital, AP-HP, Diagnosis Center, Paris, France.

Integrated Blood Pressure Control
|September 28, 2011
PubMed

Insights

Reducing systolic blood pressure (SBP) in hypertensive patients is key for cardiovascular risk reduction. De-stiffening therapies targeting arterial stiffness and wave reflections significantly improve cardiovascular outcomes.

Area of Science:

  • Cardiovascular Medicine
  • Hypertension Research
  • Pharmacology

Background:

  • Cardiovascular risk reduction in hypertensive subjects is primarily linked to decreasing systolic blood pressure (SBP).
  • Arterial stiffness and wave reflections are critical determinants of central SBP and cardiovascular remodeling.
  • Effective therapeutic strategies are needed to address these factors in managing hypertension.

Purpose of the Study:

  • To define de-stiffening therapy as a selective reduction in SBP due to decreased arterial stiffness or wave reflections.
  • To investigate the role of central SBP reduction and cardiovascular remodeling in therapeutic interventions.
  • To evaluate the efficacy of specific drug combinations in achieving cardiovascular risk reduction.

Main Methods:

  • Utilizing controlled, long-duration therapeutic trials to compare SBP reduction between study and control groups.
  • Implementing protocols involving angiotensin II blockers, potentially with diuretics or calcium-channel blockers.
  • Analyzing cardiovascular outcomes in relation to SBP reduction and underlying mechanisms.

Main Results:

  • De-stiffening therapy achieved a selective SBP reduction linked to decreased arterial stiffness and/or wave reflections.
  • Central SBP reduction and modulation of cardiovascular remodeling were key components of the observed effects.
  • Cardiovascular outcomes were significantly improved compared to control groups.

Conclusions:

  • De-stiffening therapy represents a targeted approach to managing hypertension by addressing arterial mechanics.
  • Specific drug regimens, including angiotensin II blockers, are effective in achieving SBP reduction and improving cardiovascular health.
  • The findings highlight the importance of targeting arterial stiffness for enhanced cardiovascular risk reduction in hypertensive patients.

Keywords:
de-stiffening drug therapyhypertensionlarge arteriespulse pressure

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...